4Front Ventures Corp FFNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FFNT is a good fit for your portfolio.
News
-
4Front Ventures Announces Withdrawal of Brokered Offering and Appointment of New Board Chair
-
4Front Ventures Announces Brokered Offering of Up to C$5,000,100 of Units
-
4Front Ventures Announces Opening of New Mission Dispensary in Norridge, Illinois
-
4Front Ventures Reports First Quarter 2024 Results
-
4Front Ventures to Report First Quarter 2024 Financial Results on May 17, 2024
Trading Information
- Previous Close Price
- CAD 0.12
- Day Range
- CAD 0.12–0.14
- 52-Week Range
- CAD 0.09–0.40
- Bid/Ask
- CAD 0.12 / CAD 0.14
- Market Cap
- CAD 123.55 Mil
- Volume/Avg
- 18,250 / 123,294
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.75
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 699
- Website
- https://www.4frontventures.com
Comparables
Valuation
|
Metric
|
FFNT
|
CL
|
VRNO
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 52.54 | — |
Price/Book Value | — | 1.13 | 1.12 |
Price/Sales | 0.75 | 0.73 | 1.49 |
Price/Cash Flow | — | 6.02 | 11.51 |
Price/Earnings
FFNT
CL
VRNO
Financial Strength
|
Metric
|
FFNT
|
CL
|
VRNO
|
|---|---|---|---|
Quick Ratio | 0.11 | 0.83 | 0.57 |
Current Ratio | 0.30 | 1.36 | 1.01 |
Interest Coverage | −3.36 | −0.95 | 1.26 |
Quick Ratio
FFNT
CL
VRNO
Profitability
|
Metric
|
FFNT
|
CL
|
VRNO
|
|---|---|---|---|
Return on Assets (Normalized) | −15.63% | −4.46% | −2.26% |
Return on Equity (Normalized) | — | −11.60% | −4.10% |
Return on Invested Capital (Normalized) | −20.00% | −2.45% | −0.97% |
Return on Assets
FFNT
CL
VRNO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fdtnzqpbd | Mlg | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Gypglppnb | Mmqtxj | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Bwzsvkpnf | Gqnx | $41.4 Bil | |||
| Viatris Inc
VTRS
| Slblxvhlm | Rcd | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Zdncxbx | Zsw | $13.7 Bil | |||
| Catalent Inc
CTLT
| Qkxysqyst | Qxbqcb | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Krzstsxj | Nmzc | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ychtbyc | Wxsdlgg | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Vrlwmqqk | Hnpj | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Sqlzvqfbj | Kckj | $2.7 Bil |